Home > Study Shows Keytruda Has Big Upside, Small Downside for Skin Cancer

News
Study Shows Keytruda Has Big Upside, Small Downside for Skin Cancer

Description

According to UPI, researchers claim the cancer immunotherapy drug marketed as Keytrud, was shown to have longer-lasting anti-cancer effects and fewer overall side effects than other standard treatments for advanced melanoma. In a follow-up to the phase 1 clinical trial that led to FDA approval of the drug, researchers said they saw Keytruda had greater effects with less of a downside. However, they are just analyzing the data now. The drug was approved by the FDA in 2014 for advanced melanoma treatment, but in the initial trials researchers reported effects against lung and kidney cancer, as well as fewer side effects. Former President Jimmy Carter was treated with the drug in 2015 with great success, and reported along the way that there were few side effects as he continued working during treatment. The results of the study were published in the Journal of the American Medical Association.

Added on the 22/04/2016 19:25:09 - Copyright : Wochit

To customise your video :

Or Create an account

More videos on the subject

  • New Cancer Survivor Study Shows 1/3 Battle Chronic Pain

    A new study shows that after surviving cancer, many people have to deal with lingering pain. Roughly one in three cancer survivors experience chronic pain, reports UPI. About one in six survivors has high impact pain that prevents them from performing everyday activities. Those numbers are twice as high compared to the general population. Chronic pain is a major side effect of cancer treatment that lingers well after therapy ends. It is associated with higher health costs and lower quality of life. Chronic pain for survivors was felt on most days or every day within the last six months. High impact chronic pain limited movement around the house or at work every day for six months or longer.

    20/06/2019 - Wochit
  • Study Finds Sunscreen Chemicals Are Absorbed By Our Body

    In a pilot study conducted by the Food and Drug Administration, researchers have found that people who regularly use certain types of sunscreens may be absorbing high levels of active ingredients into their bodies. Gizmodo reports that tests are ongoing and scientists caution that it’s still unclear whether these products could be posing any health risks. Health officials recommend that people continue to use sunscreen as usual for protection from sun damage.

    07/05/2019 - Wochit
  • Study Shows Primary Doctors Lack Cancer Treatment Info For Patients

    12 (UPI) -- Some doctors aren't prepared to give cancer patients basic information on how to treat the disease, new research shows. Roughly 17 percent of doctors didn't have information on surgery, radiation, or chemotherapy treatment options for women who had early-stage breast cancer, according to a study published in the journal Cancer. In addition, 22 percent of doctors in the study reported they weren't comfortable talking to patients about those options. "Primary care physicians may be involved in cancer care earlier than we thought," Lauren Wallner, a researcher at the University of Michigan Rogel Cancer Center and study author, said in a news release.

    12/02/2019 - Wochit
  • Study Shows Screen Time Doesn't Have Big Effect On Sleeping

    Research shows that children using electronic devices doesn’t significantly impact their quality of sleep. According to UPI, researchers at Oxford University collected data from the United States’ 2016 National Survey of Children’s Health. In the study parents self-reported on themselves, their children and their households. The study showed that every hour of screen time was related to 3 to 8 minutes less of sleep.

    06/11/2018 - Wochit
  • Faut-il renforcer la taxe Gafa ? Mounir Mahjoubi : "Pourquoi pas"

    @PascaledeLaTour : "Envisagez-vous de déposer un amendement pour renforcer l'efficacité de la taxe ?". @mounir : "Pourquoi pas mais on a voté une taxe qui va permettre de rapporter entre 400 et 600 millions, c'est déjà la moitié du chemin". #LaMatinaleLCI @LCI #La26.

    25/09/2019 - LCI